Shionogi will pay $2.5B to acquire one of the only approved ALS drugs
Shionogi will pay $2.5B to acquire one of the only approved ALS drugs
Contenu indisponible. Consultez la source originale.
Shionogi will pay $2.5B to acquire one of the only approved ALS drugs